38 results
Thumbnail

D1.136 - Allergen awareness of patients in allergology consultations at the pneumophthisiology department of the Ignace Deen University Hospital

Thumbnail

D1.134 - Mapping the Patient’s Journey Prior to Allergen Immunotherapy

Thumbnail

D1.135 - ”Bee Pollen” as a Potential Trigger for Anaphylaxis: A Case Study

Thumbnail

D1.137 - Characterization of Pana g 1, a novel allergen from Korean ginseng, Panax ginseng triggering Pollen-Food Allergy Syndrome

Thumbnail

D1.138 - IgE cross-reactivity between grass species in the presence of Japanese cedar pollen sensitization

Thumbnail

D1.139 - Staphylococcus aureus (carriage and sensitization) - is it a significant factor in allergic rhinitis?

Thumbnail

D1.144 - Global variations of IgE cross-reactivity in Cupressus allergy

Thumbnail

D1.145 - A Clinical Decision Support System (CDSS) based on Machine Learning for the diagnosis of Seasonal Allergenic Rhinitis (SAR) and patient-tailored AIT prescription

Thumbnail

D1.148 - Heterogeneity of sensitization profiles between Central and Southern European allergic patients

Thumbnail

- D3.24 - From angioedema to Kimura disease: Diagnostic challenge

Thumbnail

- D3.27 - Chlorhexidine as a Hidden Everyday Allergen

Thumbnail

D3.17 - Systemic Histaminergic Findings in Children with Chronic Urticaria

Thumbnail

D3.18 - Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population

Thumbnail

D3.19 - Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years

Thumbnail

D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media

Thumbnail

D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool

Thumbnail

D3.23 - Descriptive and Comparative Analysis of Clinical and Endoscopic Characteristics and Treatment Response in Adult Patients with Eosinophilic Esophagitis (EoE): a preliminary experience of an Italian centre

Thumbnail

D3.26 - Anaphylaxis associated with biosimilar Tocilizumab: in vitro and in vivo diagnosis

Thumbnail

D3.28 - Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria

Thumbnail

D3.29 - Detailed Clinical Characterization of a Large Cohort of Chronic Spontaneous Urticaria Patients